XXXX in orthopedic @entity130 : A case-control study evaluating risk factors and cost.

@entity1 @entity281 @entity174 @entity130
BACKGROUND: With the shift of our healthcare system toward a value-based system of reimbursement, complications such as surgical site infections (SSI) may not be reimbursed. The purpose of our study was to investigate the costs and risk factors of SSI for orthopedic @entity130 @entity1 . METHODS: Through retrospective analysis, 1819 @entity1 with @entity174 were identified. Of those, 78 @entity1 who developed SSIs were compared to 78 uninfected control @entity1 . @entity1 were matched by @entity174 location, type of @entity174 , duration of surgery, and as close as possible to age, year of surgery, and type of procedure. Costs for treatment during primary hospitalization and initial readmission were determined and potential risk factors were collected from @entity1 charts. A Wilcoxon test was used to compare the overall costs of treatment for case and control @entity1 . Costs were further broken down into professional fees and technical charges for analysis. Risk factors for SSIs were analyzed through a chi-squared analysis. RESULTS: Median cost for treatment for @entity1 with SSIs was  108,782 compared to  57,418 for uninfected @entity1 (p  <  0.001). Professional fees and technical charges were found to be significantly higher for infected @entity1 . No significant risk factors for SSIs were determined. CONCLUSIONS: Our findings indicate the potential for financial losses in our new healthcare system due to uncompensated care. SSIs nearly double the cost of treatment for orthopedic @entity130 @entity1 . There is no single driver of these costs. Reducing postoperative stay may be one method for reducing the cost of treating SSIs, whereas quality management programs may decrease risk of @entity281 .
